Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Short-term Investments: 2015-2016

Historic Short-term Investments for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2016 value amounting to $46.2 million.

  • Tvardi Therapeutics' Short-term Investments rose 38.18% to $91.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was $91.2 million, marking a year-over-year increase of 38.18%. This contributed to the annual value of $46.2 million for FY2016, which is 49.60% down from last year.
  • According to the latest figures from FY2016, Tvardi Therapeutics' Short-term Investments is $46.2 million, which was down 49.60% from $91.6 million recorded in FY2015.
  • Tvardi Therapeutics' Short-term Investments' 5-year high stood at $91.6 million during FY2015, with a 5-year trough of $46.2 million in FY2016.
  • Over the past 2 years, Tvardi Therapeutics' median Short-term Investments value was $68.9 million (recorded in 2015), while the average stood at $68.9 million.
  • Data for Tvardi Therapeutics' Short-term Investments shows a maximum YoY plummeted of 49.60% (in 2016) over the last 5 years.
  • Over the past 2 years, Tvardi Therapeutics' Short-term Investments (Yearly) stood at $91.6 million in 2015, then tumbled by 49.60% to $46.2 million in 2016.